Filing Details

Accession Number:
0001171843-25-002084
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-04-08 09:25:57
Reporting Period:
2025-04-07
Filing Date:
2025-04-08
Accepted Time:
2025-04-08 09:25:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1738021 Compass Therapeutics Inc. CMPX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1505148 Neil Lerner C/O Compass Therapeutics, Inc.
80 Guest Street, Suite 601
Boston MA 02135
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-04-07 20,000 $1.42 320,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.43 per share. The reporting person hereby undertakes to provide, upon request, to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, full information regarding the number of shares purchased and prices within the range set forth above.